基本信息 产品详情 公司简介 推荐产品
网站主页 ACTL8抗体 ACTL8抗体
  • ACTL8抗体
  • ACTL8抗体
  • ACTL8抗体

1/3

ACTL8抗体

Rabbit Polyclonal ACTL8 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-13

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
ACTL8抗体
英文名称:
Rabbit Polyclonal ACTL8 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3732 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
ACTL8

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/15-1/50 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesCT57
WB Predicted band size41 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human ACTL8
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 10%SDS-PAGE, Lysate: 40 μg, Lane: MCF7 cells, Primary antibody: P07761(ACTL8 Antibody) at dilution 1/300, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 5 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P07761(ACTL8 Antibody) at dilution 1/15. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P07761(ACTL8 Antibody) at dilution 1/15. (Original magnification: ×200)    


           

参考文献

以下是关于ACTL8抗体的示例参考文献(注:以下内容为假设性示例,实际文献需通过学术数据库检索):

1. **文献名称**: "ACTL8 Expression and Antibody Development in Human Cancer Tissues"

**作者**: Zhang Y, et al.

**摘要**: 本研究开发了一种针对ACTL8蛋白的单克隆抗体,验证了其在多种癌症组织中的特异性表达,并发现ACTL8在乳腺癌中的高表达与患者预后不良相关。

2. **文献名称**: "Functional Characterization of ACTL8 in Neuronal Development Using CRISPR/Cas9 and Immunostaining"

**作者**: Lee S, et al.

**摘要**: 通过CRISPR/Cas9敲除ACTL8基因并利用特异性抗体进行免疫荧光分析,揭示了ACTL8在神经元突触形成中的关键作用及其与细胞骨架重塑的关系。

3. **文献名称**: "ACTL8 Antibody Validation for Flow Cytometry in Immune Cell Profiling"

**作者**: Müller F, et al.

**摘要**: 报道了一种经过验证的ACTL8多克隆抗体,可用于流式细胞术检测免疫细胞亚群中ACTL8的表达水平,并证实其与T细胞活化相关。

4. **文献名称**: "ACTL8 as a Novel Biomarker in Ovarian Cancer: Clinical Implications of Antibody-Based Detection"

**作者**: Gupta R, et al.

**摘要**: 研究利用ACTL8特异性抗体对卵巢癌组织进行免疫组化分析,发现ACTL8可作为潜在诊断标志物,并探讨其参与肿瘤侵袭的分子机制。

---

建议通过PubMed、Google Scholar或Web of Science检索真实文献(关键词:ACTL8 antibody, ACTL8 function),并注意选择近5年内的研究以确保时效性。

       

背景信息

ACTL8 (actin-like 8) is a member of the actin-related protein (ARP) family, which shares structural homology with conventional actins but performs specialized functions in cellular processes. The ACTL8 gene encodes a protein containing conserved actin-fold domains and a unique N-terminal coiled-coil region, suggesting roles in molecular interactions or structural organization. While its precise biological function remains under investigation, ACTL8 is implicated in regulating cytoskeletal dynamics, chromatin remodeling, and intracellular transport, often through forming complexes with other ARPs or binding partners like ATPases or histone modifiers.

ACTL8 antibodies are valuable tools for studying its expression patterns, subcellular localization (e.g., cytoplasmic or nuclear), and involvement in diseases. Research links ACTL8 to cancer progression, where its dysregulation may influence cell proliferation, migration, or genomic instability. Antibody-based techniques (e.g., Western blot, immunofluorescence, or IP) have been employed to explore its interactions in pathways such as the SWI/SNF chromatin-remodeling complex. Recent studies also suggest potential roles in neurodevelopment or immune regulation, though mechanistic details are limited. Commercial ACTL8 antibodies are typically validated for specificity using knockout controls. Further research is needed to clarify its physiological and pathological significance across tissues.

       
ACTL8抗体;ACTL8;ACTL8 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

ACTL8抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价